Impact of Education Methods on HPV Knowledge and Screening Behavior
NCT ID: NCT07017387
Last Updated: 2025-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
96 participants
INTERVENTIONAL
2025-05-09
2025-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The control group will receive standard healthcare services. The first intervention group will receive three sessions of motivational interviewing-based health education on cervical cancer prevention through home visits, along with an informational brochure. The second intervention group will receive health education and a brochure, followed by a reminder session via phone. At the end of the study, participants in the control group will be offered the intervention of their choice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Face-to-face and Online Health Education on Women's Cervical Cancer Knowledge, Health Beliefs and Screening
NCT06021496
The Effect of Health Belief Model-Based Education and Motivational Interviewing on HPV (Human Papilloma Virus) Knowledge and Vaccine Awareness in Women
NCT07097766
The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors
NCT04113902
The Effect of Education Given to Women on Cervical Cancer on Knowledge, Attitude and Belief
NCT05990270
The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
NCT07320157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The control group will receive standard healthcare services. The first intervention group will receive three face-to-face educational sessions based on motivational interviewing principles on HPV and cervical cancer prevention through home visits, along with an informational brochure. These sessions will occur during Weeks 1, 2, and 3. A final follow-up session to administer FORM II will be held in Week 8.
The second intervention group will receive a single face-to-face educational session on HPV and cervical cancer prevention (Week 1), receive a brochure, and two follow-up reminder sessions via telephone in Weeks 2 and 3. FORM II will be administered in Week 8.
After the study period, participants in the control group will be offered the opportunity to choose and receive one of the two intervention methods. All participants will complete the HPV Knowledge Scale, the Cervical Cancer and Pap Smear Test Health Belief Model Scale, and a VAS for self-assessment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 2: Health Education
Participants will receive one face-to-face health education session and a brochure, followed by two reminder sessions via phone.
Health education
Participants will receive one face-to-face health education session and a brochure, followed by two reminder sessions via phone.
Arm 3: Control Group
Participants will receive standard healthcare services. At the end of the study, they will be offered the intervention of their choice.
No interventions assigned to this group
Arm 1: Motivational Interviewing-Based Health Education
Participants will receive three sessions of face-to-face health education using motivational interviewing techniques through home visits, along with an informational brochure.
Motivational interviewing based health education
Participants will receive three sessions of face-to-face health education using motivational interviewing techniques through home visits, along with an informational brochure.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational interviewing based health education
Participants will receive three sessions of face-to-face health education using motivational interviewing techniques through home visits, along with an informational brochure.
Health education
Participants will receive one face-to-face health education session and a brochure, followed by two reminder sessions via phone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being literate
* Agreeing to participate in the study
* Being female
* Being married
* Having no history of cervical cancer in first-degree relatives (mother/sister)
* Not having undergone cervical cancer screening in the last five years
* Not having been diagnosed with cancer
Exclusion Criteria
* Having been diagnosed with any type of cancer
* Having a hearing or speech impairment, or a mental disorder
* Using medication due to psychotic treatments
* Having undergone a hysterectomy
* Having had cervical cancer screening within the last five years
* Having received all three doses of the HPV vaccine
30 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Serpil Özdemir
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Incirli Family Health Center
Ankara, Kecioren, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.